Original articlePyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation

Add time:09/08/2019    Source:sciencedirect.com

Antiplatelet drugs are promising therapeutics to intervene with platelet aggregation in arterial thrombosis, most prominently in myocardial infarction and ischemic stroke. Here, we describe the synthesis and structure–activity relationships of potent inhibitors of platelet aggregation based on the 1,5-diarylpyrazol-3-carboxamide scaffold. Analogs from this series demonstrated potent anti-aggregatory activities against arachidonic acid-induced platelet aggregation, as measured by turbidimetric method of Born. 1,5-Diarylpyrazole-3-carboxamides obtained with small-basic amines (7, 8, 50, 51, 61, 62) displayed the strongest activity with IC50 values in low nanomolar range (5.7–83 nM). On the basis of their high potency in cellular environment, these straightforward pyrazole derivatives may possess potential in the design of more potent compounds for intervention with cardiovascular diseases.

We also recommend Trading Suppliers and Manufacturers of 2,4-DiMethyl-2H-pyrazole-3-carboxylic acid (cas 13745-58-9). Pls Click Website Link as below: cas 13745-58-9 suppliers

Prev:Original articleAntimitotic and vascular disrupting agents: 2-Hydroxy-3,4,5-trimethoxybenzophenones
Next:Fourier transform infrared spectroscopy applied to ink characterization of one-penny postage stamps printed 1841–1880)